galantamine has been researched along with amyloid beta-peptides in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alés, E; Arias, E; Cano-Abad, MF; Gabilan, NH; García, AG; López, MG; Villarroya, M | 1 |
| Hedberg, MM; Nordberg, A; Svedberg, MM; Unger, C; Yu, WF | 1 |
| Agostinho, P; Garção, P; Melo, JB; Oliveira, CR; Sousa, C | 1 |
| Allsop, D; Austen, B; Cooper, LJ; Gibson, G; Huckerby, TN; Matharu, B; Millichamp, R; Moore, SA; Parsons, R | 1 |
| Kano, M; Kurinami, H; Morishita, R; Niisato, K; Rakugi, H; Sato, N; Shinohara, M; Takeda, S; Takeuchi, D | 1 |
| Fang, J; Li, Q; Wu, D; Yang, M; Zhang, L; Zhang, Y | 1 |
| Mohamed, T; Osman, W; Rao, PP | 1 |
| Aarsland, D; Blennow, K; Bloniecki, V; Cummings, J; Falahati, F; Freund-Levi, Y; Winblad, B | 1 |
| Chen, X; Ma, T; Wu, Z; Zhang, Y; Zhao, L | 1 |
1 trial(s) available for galantamine and amyloid beta-peptides
| Article | Year |
|---|---|
Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cholinesterase Inhibitors; Follow-Up Studies; Galantamine; Humans; Peptide Fragments; Phosphorylation; Psychotropic Drugs; Risperidone; tau Proteins; Treatment Outcome | 2017 |
8 other study(ies) available for galantamine and amyloid beta-peptides
| Article | Year |
|---|---|
Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors.
Topics: Amyloid beta-Peptides; Analysis of Variance; Animals; Apoptosis; Blotting, Western; Bungarotoxins; Calcium; Cattle; Cell Line, Tumor; Cholinesterase Inhibitors; Chromaffin Cells; Drug Interactions; Enzyme Inhibitors; Flow Cytometry; Fura-2; Galantamine; Humans; Immunohistochemistry; Neuroblastoma; Nicotine; Peptide Fragments; Proto-Oncogene Proteins c-bcl-2; Rats; Receptors, Nicotinic; Thapsigargin | 2004 |
Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice.
Topics: Amyloid beta-Peptides; Animals; Binding Sites; Blotting, Western; Cerebral Cortex; Cholinesterase Inhibitors; Excitatory Amino Acid Antagonists; Galantamine; Immunohistochemistry; Memantine; Mice; Mice, Transgenic; Nicotine; Peptide Fragments; Radioligand Assay; Receptors, N-Methyl-D-Aspartate; Synaptophysin | 2006 |
Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Cells, Cultured; Cerebral Cortex; Cholinesterase Inhibitors; Cytoprotection; Dose-Response Relationship, Drug; Galantamine; Glutathione; Lipid Peroxidation; Nerve Degeneration; Neurons; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Plaque, Amyloid; Rats | 2009 |
Galantamine inhibits beta-amyloid aggregation and cytotoxicity.
Topics: Amyloid beta-Peptides; Analysis of Variance; Apoptosis; Cell Line, Tumor; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Galantamine; Humans; L-Lactate Dehydrogenase; Microscopy, Electron; Models, Molecular; Neuroprotective Agents; Nuclear Magnetic Resonance, Biomolecular; Peptide Fragments | 2009 |
Validation of Abeta1-40 administration into mouse cerebroventricles as an animal model for Alzheimer disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cerebral Ventricles; Cognition Disorders; Disease Models, Animal; Galantamine; Hippocampus; Injections, Intraventricular; Long-Term Potentiation; Male; Memory; Memory Disorders; Mice; Mice, Inbred C57BL; Neurotoxins; Nootropic Agents; Peptide Fragments | 2009 |
Galantamine inhibits calpain-calcineurin signaling activated by beta-amyloid in human neuroblastoma SH-SY5Y cells.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Calcineurin; Calcineurin Inhibitors; Calpain; Cell Line, Tumor; Cholinesterase Inhibitors; Galantamine; Humans; Nerve Degeneration; Neuroblastoma; Peptide Fragments; Signal Transduction | 2010 |
Investigating the binding interactions of galantamine with β-amyloid peptide.
Topics: Amyloid beta-Peptides; Binding Sites; Dimerization; Galantamine; Molecular Docking Simulation; Peptide Fragments; Protein Binding; Protein Structure, Tertiary; Thermodynamics | 2013 |
Galantamine alleviates senescence of U87 cells induced by beta-amyloid through decreasing ROS production.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Amyloid beta-Peptides; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Galantamine; Humans; Lipid Peroxidation; Neuroprotective Agents; Peptide Fragments; Reactive Oxygen Species | 2017 |